The Competitive Landscape for Immunotherapy in China
Keytruda is one of several immunotherapy drugs competing in China's rapidly growing cancer treatment market. The competitive landscape includes both international products and a growing number of domestic PD-1 and PD-L1 inhibitors, each vying for market share. Understanding this landscape helps patients, providers, and manufacturers navigate a complex and evolving market. Competitors include...
0 Commentarios 0 Acciones 314 Views 0 Vista previa